Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men

Stroke; a Journal of Cerebral Circulation
S KalmijnD Kromhout

Abstract

Cerebrovascular disease and the apolipoprotein e4 (APOE*4) allele are both important risk factors for cognitive decline. We investigated the combined effect of APOE*4 and cerebrovascular disease on cognitive decline. Data are from a cohort of 353 men, aged 69 to 89 years at baseline, living in Zutphen, Netherlands. The 30-point Mini-Mental State Examination (MMSE) was used to measure cognitive decline (drop of > 2 points) from 1990 to 1993 (14% of the sample). Odds ratios (OR [95% confidence interval]) for cognitive decline were adjusted for age, education, and baseline MMSE score. Compared with those without APOE*4 and without a history of cerebrovascular disease, the adjusted OR was 4.7 (1.7 to 12.7) for subjects without APOE*4 but with cerebrovascular disease, 3.3 (1.6 to 6.8) for those with APOE*4 and no cerebrovascular disease, and 17.2 (2.7 to 110.0) for those with both risk factors. The risk for cerebrovascular disease and APOE*4 combined was more than expected from the separate effects. The combined risk of coronary heart disease and APOE*4 was 6.1 (1.7 to 22.3). The analysis of cardiovascular risk factors showed that the risk of cognitive decline was highest in subjects with both APOE*4 and a high cholesterol level, hi...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Oct 10, 1992·Lancet·F M van Bockxmeer, C D Mamotte
Sep 1, 1992·Journal of the American Geriatrics Society·T N Tombaugh, N J McIntyre
Jan 1, 1992·Neuroepidemiology·L J Launer
Jan 1, 1990·Genetic Epidemiology·R Ottman
Mar 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·T KuusiM R Taskinen
Nov 1, 1988·Psychological Medicine·G G FillenbaumD G Blazer
Jan 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J DavignonC F Sing
Aug 26, 1995·Lancet·M J AlbertsA D Roses
Nov 5, 1994·BMJ : British Medical Journal·E J FeskensD Kromhout
Sep 18, 1993·Lancet·J PoirierS Gauthier
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses

❮ Previous
Next ❯

Citations

May 13, 2009·Archives of Neurology·David S KnopmanRonald C Petersen
Jan 25, 2005·Current Diabetes Reports·Lenore J Launer
Sep 12, 2000·Current Hypertension Reports·M L Seux, F Forette
Sep 4, 2007·Current Neurology and Neuroscience Reports·Rachel A Whitmer
Nov 6, 2002·Journal of the Neurological Sciences·A FrankP Barreiro
Jan 9, 2013·Nature Reviews. Neurology·Chia-Chen LiuGuojun Bu
Mar 21, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·E L HelkalaJ T Salonen
May 6, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·R Stewart, D Liolitsa
Jan 10, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·M W J StrachanI J Deary
Mar 30, 2010·Médecine sciences : M/S·Séverine SabiaArchana Singh-Manoux
Jul 24, 2008·European Heart Journal·Archana Singh-ManouxMartin J Shipley
Mar 24, 2007·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Cindy M de FriasLars-Göran Nilsson
Feb 5, 2010·Dementia and Geriatric Cognitive Disorders·Ramit Ravona-SpringerMichal Schnaider Beeri
Jun 25, 2005·Drugs & Aging·Marie-Anne Mackowiak-CordolianiFlorence Pasquier
Jan 1, 2008·The Libyan Journal of Medicine·Bc Mathew, Rs Biju
Nov 11, 2014·Journal of the International Neuropsychological Society : JINS·Georgina E CrichtonMichael A Robbins
May 1, 2008·The British Journal of Radiology·D S Knopman
Jan 27, 2011·The Journal of Nutrition, Health & Aging·Q GaoTze Pin Ng
Oct 22, 2011·Expert Review of Neurotherapeutics·Ramit Ravona-Springer, Michal Schnaider-Beeri
Dec 18, 2013·Seminars in Oncology·Jeanne S MandelblattUNKNOWN Thinking and Living With Cancer Study
Apr 23, 2013·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Katherine J BangenRhoda Au
Apr 27, 2012·The American Journal of Geriatric Pharmacotherapy·Robert D NebesJudith A Saxton
Mar 17, 2010·Life Sciences·Akiko SakataMasatsugu Horiuchi
Feb 14, 2006·Mayo Clinic Proceedings·David S Knopman
Sep 9, 2008·The American Journal of Emergency Medicine·Viviane MontoutJacques Boddaert
Jun 3, 2008·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Roger C M HoTze-Pin Ng
Dec 23, 2003·Journal of the American Geriatrics Society·Robert StewartAnthony Mann
Feb 18, 2009·Journal of the American Geriatrics Society·Katie L StoneSteven R Cummings
Aug 18, 2006·Journal of the American Geriatrics Society·Katie L StoneSteven R Cummings
Nov 6, 2007·Journal of the American Geriatrics Society·Chris J PackardUNKNOWN Prospective Study of Pravastatin in the Elderly at Risk Group
Dec 5, 2009·International Journal of Geriatric Psychiatry·Jørgen WagleKnut Engedal
Jan 18, 2005·Neurobiology of Aging·Jae Hee KangFrancine Grodstein
Apr 17, 2002·Biological Psychiatry·Kristine YaffePhilip Morin
Apr 17, 2012·Neurobiology of Aging·Camilla FerrariLaura Fratiglioni
Dec 17, 2014·Age and Ageing·Angela L JeffersonRhoda Au

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.